• Home /
  • Developing Drug Products in an Aging Society (eBook)

Developing Drug Products in an Aging Society (eBook)

From Concept to Prescribing
Artikelnummer: 978-3-319-43099-7
Einband: PDF
Verfügbarkeit: Download, sofort verfügbar (Link per E-Mail)
CHF 212.50
decrease increase
This book aims to address the major aspects of future drug product development and therapy for older adults, giving practical guidance for the rational product and clinical development and prescribing of drug products to this ever growing segment of the population. With authors coming from key "aging" markets such as Europe, the USA, China and Japan, the book will provide valuable information for students, scientists, regulators, practitioners, and other healthcare professionals from academia, industry and regulatory bodies.
This book aims to address the major aspects of future drug product development and therapy for older adults, giving practical guidance for the rational product and clinical development and prescribing of drug products to this ever growing segment of the population. With authors coming from key "aging" markets such as Europe, the USA, China and Japan, the book will provide valuable information for students, scientists, regulators, practitioners, and other healthcare professionals from academia, industry and regulatory bodies.
Schreiben Sie Ihre eigene Bewertung
  • Nur registrierte Benutzer können Produkte bewerten
*
*
Schlecht
Sehr gut
*
*
*
*
VerlagSpringer Nature Switzerland
EinbandPDF
Erscheinungsjahr2016
Seitenangabe771 S.
AusgabekennzeichenEnglisch
AbbildungenXVIII, 771 p. 96 illus., 85 illus. in color.
Masse12'915 KB
PlattformPDF
ReiheAAPS Advances in the Pharmaceutical Sciences Series
AutorStegemann, Sven (Hrsg.)

Alle Bände der Reihe "AAPS Advances in the Pharmaceutical Sciences Series"

Über den Autor Sven (Hrsg.) Stegemann

Sven Stegemann is the endowed professor for Patient-Centric Drug Product Design and Manufacturing at the Graz University of Technology and Director of Pharmaceutical Business Development at Capsugel. He is scientist, professor and advocate for multidisciplinary research on patient-centric drug products and affordable medicines. Prof. Stegemann trains the next generation of pharmaceutical scientists. His professional experience spans all stages of drug development and manufacturing--from early development through commercial manufacturing.His passion and research led him to found the Geriatric Medicine Society e.V. in 2009, a multidisciplinary network that aims to facilitate the development of age-appropriate medicines that older patients can easily and safely take. He also serves in various organizations as chairman or committee member to progress pharmaceutical sciences.He has established a focus group on patient-centric drug development through the American Association of Pharmaceutical Scientists (AAPS).As This is integral to improving the quality of life of patients in the future.He has spoken at innumerable conferences around the world on patient-centric drug delivery, pharmaceutical product development for special patient populations, multiparticulate technologies, adherence, geriatric drug delivery, quality by design and added value generics.

Weitere Titel von Sven (Hrsg.) Stegemann

Produktbewertungen
Nur registrierte Benutzer können Produkte bewerten